Published : Jun-2018
No. of Pages : 55
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 CMV: Executive Summary 4
2.1 Related Reports 5
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 7
3.3 Global and Historical Trends 8
3.3.1 CMV Disease in Diagnosed Prevalent HIV Patients 9
3.3.2 CMV Disease in SOT Patients 10
3.3.3 CMV Disease in Allo-HSCT Patients 10
3.3.4 Congenital CMV Disease 11
3.4 Forecast Methodology 11
3.4.1 Sources 12
3.4.2 Forecast Assumptions and Methods 17
3.5 Epidemiological Forecast for CMV (2017-2027) 28
3.5.1 Diagnosed Incident Cases of CMV 28
3.5.2 Age-Specific Incident Cases of CMV 29
3.5.3 Sex-Specific Diagnosed Incident Cases of CMV 30
3.5.4 CMV Diagnosed Incident Cases by Population at Risk 31
3.5.5 HIV-CMV 32
3.5.6 SOT Patients 34
3.5.7 SOT-CMV 35
3.5.8 HSCT Patients 36
3.5.9 HSCT-CMV 37
3.5.10 Diagnosed Incident Cases of Congenital CMV 38
3.6 Discussion 39
3.6.1 Epidemiological Forecast Insight 39
3.6.2 Limitations of Analysis 40
3.6.3 Strengths of Analysis 40
4 Appendix 42
4.1 Bibliography 42
4.2 About the Authors 52
4.2.1 Epidemiologist 52
4.2.2 Reviewers 52
4.2.3 Global Director of Therapy Analysis and Epidemiology 53
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 53
4.3 About GlobalData 54
4.4 Contact Us 54
4.5 Disclaimer 54
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for CMV 8
1.2 List of Figures
Figure 1: 7MM, Diagnosed Incident Cases of CMV, Both Sexes, All Ages, 2017 and 2027 5
Figure 2: Age-Standardized Diagnosed Incidence of CMV Disease, All Ages, 2017 9
Figure 3: Case Flow Map 11
Figure 4: Sources Used and Not Used for Calculations of Diagnosed Incident Cases of HIV-CMV 12
Figure 5: Sources Used and Not Used for Calculations of SOT Patients 13
Figure 6: Sources Used and Not Used for Calculations of Diagnosed Incident Cases of SOT-CMV 14
Figure 7: Sources Used and Not Used for Calculations of Allo-HSCT Patients and Diagnosed Incident Cases of HSCT-CMV 15
Figure 8: Sources Used and Not Used for Calculations of Live Births and cCMV Cases 16
Figure 9: Diagnosed Incident Cases of CMV, 7MM, Men and Women, All Ages, 2017 29
Figure 10: 7MM, Age-Specific Diagnosed Incident Cases of CMV Disease, Men and Women, 2017 30
Figure 11: 7MM, Sex-Specific Diagnosed Incident Cases of CMV Disease, All Ages, 2017 31
Figure 12: 7MM, Diagnosed Incident Cases of CMV Disease by Population at Risk, Men and Women, All Ages, 2017 32
Figure 13: 5EU and Japan, Diagnosed Incident Cases of HIV-CMV, Men and Women, All Ages, 2017-2027 33
Figure 14: US, Diagnosed Incident Cases of HIV-CMV, Men and Women, All Ages, 2017-2027 33
Figure 15: 7MM, SOT Patients, Men and Women, All Ages, 2017-2027 34
Figure 16: 7MM, Diagnosed Incident Cases of SOT-CMV, Men and Women, All Ages, 2017-2027 35
Figure 17: 7MM, Allo-HSCT Patients, Men and Women, All Ages, 2017-2027 36
Figure 18: 7MM, Diagnosed Incident Cases of HSCT-CMV, Men and Women, All Ages, 2017-2027 37
Figure 19: 5EU and Japan, Diagnosed Incident Cases of cCMV, Men and Women, All Ages, 2017-2027 38
Figure 20: US, Diagnosed Incident Cases of cCMV, Men and Women, All Ages, 2017-2027 39
